Tinazoline

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C11H11N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88174AK70T, chemically known as 1h-indole, 3-((4,5-dihydro-1h-imidazol-2-yl)thio)-, monohydrochloride but generally known as tinazoline, which bears US NIH Compound Identifier 68818. European Medicines Agency schedules Tinazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11073MIG. The term TINAZOLINE is an International Non-Proprietary Name. TINAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tinazoline under HS 29332990 and SITC 51573. As of Q4 2014, TINAZOLINE remains the US FDA Preferred Term for this commodity. Tinazoline bears US NLM identifiers UMLS ID C0076698 and NCI Concept Code C75057. SMILES: C1CN=C(N1)SC2=CNC3=CC=CC=C32.